The 3 most recent market catalysts affecting $SNOA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 75
Sonoma Pharmaceuticals shares are trading higher after the company reported a year-over-year increase in Q1 financial results.
The reported year-over-year increase in Q1 financial results for Sonoma Pharmaceuticals is a significant positive catalyst for the company. This indicates improved operational perf…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 75
Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoY
Sonoma Pharmaceuticals (SNOA) disclosed its Q1 earnings, showing a significant reduction in losses per share from $(0.76) to $(0.09) and a substantial 59.55% increase in sales to $…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue
Sonoma Pharmaceuticals (SNOA) announced a significant financial turnaround, achieving positive EBITDA for the first time in its history, alongside record quarterly revenue. This is…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.